December 5, 2024
- All
- Arbitration
- Asbestos
- Asbestos-Related Illness
- Benzene
- Brayton Purcell News
- Chemicals and Toxic Substances
- Congress and Politics
- Consumer Safety
- Dangerous Medical Drugs
- Defective Medical Devices
- Elder Abuse
- Emissions-cheating scandal
- Engineered Stone
- Estate Planning
- Firm News
- Legal News
- Medical Malpractice
- Medical News
- Mesothelioma
- Mortgage Fraud
- Occupational Asbestos Exposure
- Product Liability
- Product Recalls
- Safety Tips
- Safety Violations
- Schools
- Tobacco
- Uncategorized
- Veterans’ News
- Whistleblowing
- Workers’ Compensation
- Workers’ Rights
November 26, 2024
November 19, 2024
November 13, 2024
March 29, 2024
January 10, 2024
December 28, 2023
June 2, 2023
After years of litigation, the Hess Corporation agreed to settle hundreds of asbestos exposure lawsuits filed on the island of St. Croix. The company will establish a $106 million trust for victims, their surviving family members, and those that may be diagnosed in the future. A Hess-owned oil refinery operated on the island from 1965 to 1998, and exposed workers and people staying on the island to asbestos and benzene. Hess will provide $90 million in compensation for mesothelioma and other claimants who have filed for compensation. An additional $15 million is being set aside to benefit those who may be […]
March 14, 2023
CIMAvax-EGF is a new lung cancer treatment that “harnesses the body’s immune system to fight lung cancer.” They began testing the drug in 2017; another trial is testing the drug for the prevention of lung cancer in patients who are at high risk. CIMAvax-EGF blocks a certain protein (epidermal growth factor (EGF)) that cancer cells need to grow. The drug works by starving the cancer cells by preventing EGF from attaching to the cell. If the cancer cell cannot multiply, it dies. They have treated more than 5,000 lung cancer patients so far with this unique immunotherapy. Several international studies […]
January 10, 2023
Base editing is a revolutionary technology that has the potential to revolutionize the treatment of mesothelioma. This technology allows scientists to make precise, targeted changes to a patient’s genetic code, without introducing any foreign DNA into the patient’s body. This technology has the potential to be used to treat cancer and other genetic diseases. A young patient with leukemia is now clear of the cancer after base editing therapy. In the future, base editing could be used to create personalized treatments for mesothelioma. By analyzing a patient’s genetic code, doctors could determine the best approach to treating their mesothelioma. This […]
